The effect of ICAD-S on the formation and intracellular distribution of a nucleolytically active caspase-activated DNase.

We show here that co-expression of murine CAD with either ICAD-L or ICAD-S in Escherichia coli as well as mammalian cells leads to a functional DFF complex, which after caspase-3 activation releases a nucleolytically active DNase. The chaperone activity of ICAD-S is between one and two orders of magnitude less effective than that of ICAD-L, as deduced from cleavage experiments with different activated recombinant DFF complexes produced in E.coli. With nucleolytically active EGFP fusion proteins of CAD it is demonstrated that co-expression of ICAD-S, which lacks the C-terminal domain of ICAD-L, including the NLS, leads to a homogeneous intracellular distribution of the DNase in transfected cells, whereas co-expression of human or murine ICAD-L variants lacking the NLS leads to exclusion of EGFP-CAD from the nuclei in approximately 50% of cells. These results attribute a particular importance of the NLS in the long isoform of the inhibitor of CAD for nuclear accumulation of the DFF complex in living cells. It is concluded that ICAD-L and ICAD-S in vivo might function as tissue-specific modulators in the regulation of apoptotic DNA degradation by controlling not only the enzymatic activity but also the amount of CAD available in the nuclei of mammalian cells.

[1]  A. Pingoud,et al.  Involvement of conserved histidine, lysine and tyrosine residues in the mechanism of DNA cleavage by the caspase-3 activated DNase CAD. , 2002, Nucleic acids research.

[2]  S. Nagata,et al.  Co-translational Folding of Caspase-activated DNase with Hsp70, Hsp40, and Inhibitor of Caspase-activated DNase* , 2002, The Journal of Biological Chemistry.

[3]  A. Pingoud,et al.  Identification of functionally relevant histidine residues in the apoptotic nuclease CAD. , 2001, Nucleic acids research.

[4]  T. Shiraishi,et al.  Expression of ICAD‐L and ICAD‐S in Human Brain Tumor and Its Cleavage upon Activation of Apoptosis by Anti‐Fas Antibody , 2001, Japanese journal of cancer research : Gann.

[5]  G. Wagner,et al.  Solution structure of DFF40 and DFF45 N-terminal domain complex and mutual chaperone activity of DFF40 and DFF45 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Xiao-Ming Yin,et al.  Characterization of the Rat DNA Fragmentation Factor 35/Inhibitor of Caspase-activated DNase (Short Form) , 2000, The Journal of Biological Chemistry.

[7]  Toshio Yamazaki,et al.  Structure of the heterodimeric complex between CAD domains of CAD and ICAD , 2000, Nature Structural Biology.

[8]  J. Rommens,et al.  Determinants of the Nuclear Localization of the Heterodimeric DNA Fragmentation Factor (Icad/Cad) , 2000, The Journal of cell biology.

[9]  Y. Kyōgoku,et al.  Structure of the CAD domain of caspase-activated DNase and interaction with the CAD domain of its inhibitor. , 2000, Journal of molecular biology.

[10]  S. Nagata.  Apoptotic DNA fragmentation. , 2000, Experimental cell research.

[11]  S. Nagata,et al.  Specific Chaperone-like Activity of Inhibitor of Caspase-activated DNase for Caspase-activated DNase* , 2000, The Journal of Biological Chemistry.

[12]  W. Earnshaw,et al.  Differential localization of ICAD-L and ICAD-S in cells due to removal of a C-terminal NLS from ICAD-L by alternative splicing. , 2000, Experimental cell research.

[13]  G. Wagner,et al.  Solution Structure of the CIDE-N Domain of CIDE-B and a Model for CIDE-N/CIDE-N Interactions in the DNA Fragmentation Pathway of Apoptosis , 1999, Cell.

[14]  J. McCarty,et al.  Multiple domains of DFF45 bind synergistically to DFF40: roles of caspase cleavage and sequestration of activator domain of DFF40. , 1999, Biochemical and biophysical research communications.

[15]  J. McCarty,et al.  Study of DFF45 in its role of chaperone and inhibitor: two independent inhibitory domains of DFF40 nuclease activity. , 1999, Biochemical and biophysical research communications.

[16]  Mei X. Wu,et al.  Functional Interaction of DFF35 and DFF45 with Caspase-activated DNA Fragmentation Nuclease DFF40* , 1999, The Journal of Biological Chemistry.

[17]  S. Nagata,et al.  Functional Differences of Two Forms of the Inhibitor of Caspase-activated DNase, ICAD-L, and ICAD-S* , 1999, The Journal of Biological Chemistry.

[18]  X. Liu,et al.  Activation of the Apoptotic Endonuclease DFF40 (Caspase-activated DNase or Nuclease) , 1999, The Journal of Biological Chemistry.

[19]  P. Li,et al.  The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Chen,et al.  CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor , 1998, The EMBO journal.

[21]  A. Roulston,et al.  CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45 , 1998, Current Biology.

[22]  A. Pingoud,et al.  Biochemical characterization of Anabaena sp. strain PCC 7120 non-specific nuclease NucA and its inhibitor NuiA. , 1998, European journal of biochemistry.

[23]  S. Nagata,et al.  Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis , 1998, Nature.

[24]  S. Nagata,et al.  A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.

[25]  R. Tsai,et al.  Using a eukaryotic GST fusion vector for proteins difficult to express in E. coli. , 1997, BioTechniques.

[26]  Xiaodong Wang,et al.  DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis , 1997, Cell.

[27]  S. Ruben,et al.  I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. , 1992, Genes & development.